/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on a claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies.
MINNEAPOLIS, May 25, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 Jefferies Healthcare. | May 25, 2023
MINNEAPOLIS, May 12, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets. | May 12, 2023
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the BofA.